These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5505413)

  • 1. [Genetic markers and their interrelationships in influenza viruses. 3. The interrelationship between virulence and sensitivity to serum inhibitors, neuraminidase and eluting activity].
    Sokolov MI; Shvachkina VI; Molibog EV
    Vopr Virusol; 1970; 15(4):488-92. PubMed ID: 5505413
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic markers and their variability in influenza viruses isolated from the 1968-1969 influenza epidemic. I. The biologic properties of strains of variety A2 (Hong Kong) 1-68].
    Sokolov MI; Podcherniaeva RIa; Parasiuk NA; Miasnikova IA; Men'shikh LK
    Vopr Virusol; 1970; 15(6):677-80. PubMed ID: 5518642
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro characteristics of largely genetically homogenous influenza virus A2 strains].
    Gerth HJ
    Arch Gesamte Virusforsch; 1970; 30(4):275-90. PubMed ID: 4318622
    [No Abstract]   [Full Text] [Related]  

  • 4. [The behavior of genetically purified influenza A2 strains in cell cultures].
    Gerth HJ
    Zentralbl Bakteriol Orig; 1970; 215(1):26-37. PubMed ID: 4992213
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum inhibitors of A 2 -Hong Kong influenza virus haemagglutination.
    Shortridge KF; Lansdell A
    Microbios; 1972 Dec; 6(24):213-9. PubMed ID: 4348986
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory characteristics of influenza A viruses attenuated for man.
    Willers H; Beare AS
    Arch Gesamte Virusforsch; 1970; 30(2):187-94. PubMed ID: 5466137
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory markers of virulence in influenza viruses.
    Hobson D; Gould EA
    Prog Immunobiol Stand; 1967; 3():70-2. PubMed ID: 5379960
    [No Abstract]   [Full Text] [Related]  

  • 8. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A-equi-2 viruses isolated in Switzerland, 1965-1966. A comparative antigenic study.
    Paccaud MF; Paccaud M
    Pathol Microbiol (Basel); 1967; 30(6):999-1006. PubMed ID: 5627204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serological studies of largely genetically homogenous influenza A2 strains].
    Gerth HJ
    Arch Gesamte Virusforsch; 1970; 30(4):291-302. PubMed ID: 5466224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic markers and their interrelationships in influenza virus. 2. Viremia in mice infected with virulent and non-virulent strains of influenza virus and its relationship to virulence].
    Shvachkina VI; Sokolov MI; Parasiuk NA
    Vopr Virusol; 1969; 14(5):629-32. PubMed ID: 5407011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between toxicity of influenza A2 virus strains, their sensitivity to inhibitors and enzymatic activity].
    Koveza TN; Gorbunova AS
    Vopr Virusol; 1972; 17(1):115-7. PubMed ID: 5013476
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and in vitro properties of inhibitor-nonsensitive influenza A(H3N2) strains.
    Lecomte J; Boudreault A; Pavilanis V
    Can J Microbiol; 1974 Apr; 20(4):491-8. PubMed ID: 4857251
    [No Abstract]   [Full Text] [Related]  

  • 17. Temperature optima of neuraminidase activity of influenza viruses.
    Golubev DB; Aptekareva MN; Ivanova NA; Bykov SE; Ivannikov YG
    Acta Virol; 1973 Jul; 17(4):281-6. PubMed ID: 4148206
    [No Abstract]   [Full Text] [Related]  

  • 18. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
    Sun J; Mei H
    Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.
    Ho HT; Hurt AC; Mosse J; Barr I
    Antiviral Res; 2007 Dec; 76(3):263-6. PubMed ID: 17868928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic markers and their interrelationship in influenza viruses. 4. The thermoresistance of infectious and hemagglutinating properties and their relationship to virulence for mice].
    Sokolov MI; Shvachkina VI; Parasiuk NA; Meshchaninova LI
    Vopr Virusol; 1970; 15(5):561-6. PubMed ID: 5534121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.